TelyRx Holdings Inc.
PosiFunda Ratios Only on PositoAI
PositoAI's own ratios from TelyRx Holdings Inc.'s yearly results, compared with Healthcare companies in United States. Tap ? on any ratio for what it means.
Where $100 of sales goes
Latest year (Dec 2025). Taxes and other income are not shown, so the parts need not add up to 100.
Cash quality
Profit Cash Ratio
—Data incomplete
Self-Funding Ratio
—Data incomplete
Cash Locked Ratio
—Data incomplete
Growth quality
Steadiness Ratio
—Data incomplete
Growth Efficiency Ratio
—Data incomplete
Asset Productivity Ratio
—Data incomplete
Balance-sheet strength
Debt Due Cover Ratio
-0.1×Operating cash was negative last year, while some debt falls due within a year.
Higher than 68% of Healthcare companies in United States.
Cash Cushion Ratio
—Data incomplete
Tangible Assets Ratio
89%Of every $100 the company owns, $89 is in tangible assets such as plants, cash, stock and receivables; the rest is goodwill and other intangibles.
More tangible than 61% of Healthcare companies in United States.
Tangible Net Worth Ratio
—Data incomplete
Shareholders
Standard fundamentals
P/E, P/B, ROE, debt, growth and more (11)
TelyRx Holdings Inc. made a loss over the last year. TelyRx Holdings Inc. owes $0.65 for every $1 it owns. TelyRx Holdings Inc. made a loss in each of the last two years.
Compared with Healthcare companies in United States · latest annual results Dec 2025.
P/E ratio
LossTelyRx Holdings Inc. made a loss over the last year, so its P/E ratio is not meaningful.
P/B ratio
4.07The share price is 4.07 times TelyRx Holdings Inc.'s book value per share, higher than 65% of Healthcare companies in United States.
Market cap
C$62 MThe total market value of all of TelyRx Holdings Inc.'s shares at today's price (share price × number of shares), smaller than 75% of Healthcare companies in United States. PosiCap size class: Micro Cap.
Net worth (book value)
$11 MWhat TelyRx Holdings Inc. would have left on paper if it sold everything it owns and paid everything it owes, from its latest balance sheet (30 Jun 2026).
Owes vs Owns
0.65×TelyRx Holdings Inc. owes $0.65 for every $1 it owns (moderate), higher than 68% of Healthcare companies in United States.
Dividend yield
NoneTelyRx Holdings Inc. does not currently pay a dividend.
Revenue growth
+350%Revenue rose 350% in the year to Dec 2025.
Profit growth
LossTelyRx Holdings Inc. made a loss in each of the last two years.
Profit margin
-12.6%TelyRx Holdings Inc. lost $13 for every $100 of revenue.
Interest cover
Not coveredTelyRx Holdings Inc.'s operating profit did not cover its interest costs in the year to Dec 2025.
Cash vs debt
Net debtTelyRx Holdings Inc. had $9 M more debt than cash (net debt) at Dec 2025.
Questions
How much does TelyRx Holdings Inc. owe compared with what it owns?
TelyRx Holdings Inc. owes $0.65 for every $1 it owns (moderate), higher than 68% of Healthcare companies in United States.
Does TelyRx Holdings Inc. pay a dividend?
No. TelyRx Holdings Inc. does not currently pay a dividend.
Is TelyRx Holdings Inc.'s revenue growing?
Revenue rose 350% in the year to Dec 2025.
Figures from the company's yearly results and PositoAI's own data. Full tables are on the Go Deep tab. What each figure means. PositoAI is for research and education only and is not investment advice.